News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cosmederm Gains CFDA Approval for Topical Skin Treatment



8/12/2013 2:57:22 PM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

August 12, 2013 -- Cosmederm Bioscience of San Diego, Hong Kong and Shenzhen, received CFDA approval for TriCalm® Anti-Itch Hydrogel, an OTC topical treatment for itching, burning or stinging skin conditions. In April 2013, the company’s Tricalm Eczema Creme was approved for marketing by the CFDA, its first China approval. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES